Skip to main content

Table 3 Perioperative results and treatment outcomes

From: Opioid-sparing anesthesia with dexmedetomidine provides stable hemodynamic and short hospital stay in non-intubated video-assisted thoracoscopic surgery: a propensity score matching cohort study

Variables

Group D

(N = 50)

Group O

(N = 50)

p

Anesthetic induction duration (min)

26.9 ± 9.4

22.2 ± 9.2

< 0.05a

Bupivacaine consumption via epidural catheter (mg)

14.5 ± 3

13.7 ± 2.7

0.54

Propofol consumption (mg)

294.1 ± 34.1

324.5 ± 39.1

0.08

Intraoperative blood loss (ml)

< 30

< 30

1.00

Intraoperative complication

0 (0)

0 (0)

1.00

Conversion to thoracotomy

0 (0)

0 (0)

1.00

Intraoperative alfentanil consumption (μg)

 

742 ± 339.3

 

Postoperative pain control

 Morphine consumption (mg)

1.1 ± 1.8

2.4 ± 3.8

< 0.05a

 Parecoxib (Dynastat®) (mg)

31.2 ± 16.7

27.2 ± 29.6

0.42

 Tramal (mg)

2 ± 14.1

2 ± 14.1

1

 Ultracet® (tab)

1.08 ± 2.53

0.86 ± 0

0.55

 Diclofenac (tab)

0 ± 0.1

0.5 ± 1.6

< 0.01b

 Tramadol 37.5 mg + Acetaminophen 325 mg (Traceton®) (tab)

0

0.4 ± 1

< 0.01b

Postoperative hospital stay (days)

1.8 ± 0.8

2.9 ± 1.6

< 0.001c

Total hospital stay (days)

4.5 ± 0.9

5.8 ± 2.7

< 0.01b

  1. Continuous data are presented as the mean ± standard deviation, and categorical data are presented as n (%)
  2. ap < 0.05 indicates a significant difference between groups D and O
  3. bp < 0.01 indicates a highly significant difference between groups D and O
  4. cp < 0.001 indicates an extremely significant difference between groups D and O
  5. Key: PONV Postoperative, nausea and vomiting